Cargando…
Update on the Treatment of Metastatic Urothelial Carcinoma
Platinum-based combination chemotherapy has been the standard of care in the first-line treatment of metastatic urothelial carcinoma (mUC). Treatment of metastatic disease following progression on platinum-based regimens has evolved significantly in the last few years. Clinical trials are currently...
Autores principales: | Bukhari, Nedal, Al-Shamsi, Humaid O., Azam, Faisal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011065/ https://www.ncbi.nlm.nih.gov/pubmed/29977169 http://dx.doi.org/10.1155/2018/5682078 |
Ejemplares similares
-
Metastatic Type II Papillary Renal Cell Carcinoma With Recurrent Complete Responses to Sunitinib: A Case Report With a Literature Review
por: Al Ashour, Bayan H, et al.
Publicado: (2022) -
Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges
por: Rafii, Saeed, et al.
Publicado: (2022) -
Sunitinib: An Unusual Cause of Pneumothorax in a Patient With Metastatic Chromophobe Renal Cell Carcinoma
por: Bukhari, Nedal, et al.
Publicado: (2020) -
Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature
por: Bukhari, Nedal, et al.
Publicado: (2021) -
Update on Chemotherapy in the Treatment of Urothelial Carcinoma
por: Costantini, Carrie, et al.
Publicado: (2011)